Entrada Therapeutics, Inc.

Q4 2022 13F Holders

Symbol
TRDA
CUSIP
29384C108
Type
Equity
Class
COM
Num filings
49
Total reported value, excl. options
$335 M
Manager Report Date Value ($000) Shares Option Type